Analysts expect Kura Oncology, Inc. to report revenue of 22.30 M for Q3 26, against a range of 21.09 M to 23.51 M. The most recent reported quarter, Q2 26, came in at 20.87 M, a 1.2% miss against the 21.13 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 53.88 M | 14.11 M | 15.29 M | 20.75 M | 17.34 M | 18.27 M | 20.87 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 56.13 M | 17.93 M | 43.44 M | 21.50 M | 37.91 M | 29.45 M | 22.77 M | 23.51 M | 33.75 M | 47.41 M | 48.82 M | 53.84 M | 55.50 M | 67.28 M | 70.23 M | ||||||||||
| Low Estimate | 0.00 | 48.00 M | 15.29 M | 37.32 M | 18.40 M | 34.42 M | 25.12 M | 19.48 M | 21.09 M | 31.03 M | 40.61 M | 41.95 M | 47.55 M | 51.56 M | 55.13 M | 65.90 M | ||||||||||
| Consensus Estimate | 0.00 | 52.07 M | 16.61 M | 40.38 M | 19.95 M | 36.16 M | 27.29 M | 21.13 M | 22.30 M | 32.39 M | 44.01 M | 45.39 M | 50.70 M | 53.53 M | 61.20 M | 68.07 M |
Analysts expect Kura Oncology, Inc. to report earnings per share of -0.85 for Q3 26, against a range of -0.93 to -0.77. The most recent reported quarter, Q2 26, came in at -0.77, a 10.5% beat against the -0.86 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.63 | -0.22 | -0.66 | -0.75 | -0.85 | -0.92 | -0.83 | -0.77 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.63 | -0.62 | -0.53 | -0.32 | -0.72 | -0.64 | -0.81 | -0.81 | -0.77 | -0.70 | -0.64 | -0.58 | -0.60 | -0.61 | -0.47 | -0.35 | ||||||||||
| Low Estimate | -0.69 | -0.74 | -0.61 | -0.38 | -0.78 | -0.72 | -0.93 | -0.91 | -0.93 | -0.82 | -0.72 | -0.68 | -0.72 | -0.75 | -0.51 | -0.41 | ||||||||||
| Consensus Estimate | -0.66 | -0.68 | -0.57 | -0.35 | -0.75 | -0.68 | -0.87 | -0.86 | -0.85 | -0.76 | -0.68 | -0.63 | -0.66 | -0.68 | -0.49 | -0.38 |
Pull Wall Street consensus for Kura Oncology, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=KURA&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "KURA", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=KURA&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();